Pronounced Benefit of Coronary Stenting and Adjunctive Platelet Glycoprotein IIb/IIIa Inhibition in Complex Atherosclerotic LesionsFernando Cura, Eric J. Topol, David J. Moliterno et al.|Circulation|2000Cited by 76
Meta-Analysis of Long-Term Outcomes for Drug-Eluting Stents Versus Bare-Metal Stents in Primary Percutaneous Coronary Interventions for ST-Segment Elevation Myocardial InfarctionEric Wallace, Khaled M. Ziada, Rahul Matnani et al.|The American Journal of Cardiology|2012Cited by 32
Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second‐generation drug‐eluting stents for coronary artery disease: A systematic review and meta‐analysis of randomized trialsKhaled M. Ziada, David J. Moliterno, Ahmed Abdel‐Latif et al.|Catheterization and Cardiovascular Interventions|2015Cited by 22
Heparin-induced thrombocytopenia and cardiovascular diseasesPranab Das, Debabrata Mukherjee, Khaled M. Ziada et al.|American Heart Journal|2006Cited by 16
Revascularisation for patients with stable coronary artery diseaseKhaled M. Ziada, David J. Moliterno|BMJ|2014Cited by 3